GH-, PRL-, POMC-, β-TSH-, β-LH-, β-FSH-mRNA in Gonadotroph Adenomas of the Pituitary by In Situ Hybridization in Comparison with Immunostaining and Clinical Data

By Münscher A.   Schmid M.   Saeger W.   Schreiber S.   Lüdecke D.K.  

Endocrine Pathology, Vol. 12, Iss. 2, 2001-06 ,pp. : 171-180

Humana Press, Inc

Access to resources Recommend Favorite

TSH Receptor Mutations and Thyroid Disease

By Duprez L.   Parma J.   Van Sande J.   Rodien P.   Dumont J.E.   Vassart G.   Abramowicz M.  

Trends in Endocrinology and Metabolism, Vol. 9, Iss. 4, 1998-12 ,pp. : 133-140

Elsevier

Access to resources Recommend Favorite

“Honeycomb Golgi” in pituitary adenomas: Not a marker of gonadotroph adenomas

By Sano Toshiaki   Mader Rene   Asa Sylvia   Qian Zhi   Hino Akiko   Yamada Shozo  

Endocrine Pathology, Vol. 14, Iss. 4, 2003-12 ,pp. : 363-368

Humana Press, Inc

Access to resources Recommend Favorite

The History of the Treatment of Pituitary Adenomas

By Maartens Nicholas F.  

Endocrine Journal, Vol. 28, Iss. 1, 2005-10 ,pp. : 9-26

Humana Press, Inc

Access to resources Recommend Favorite

CD markers in pituitary adenomas

By Saeger Wolfgang  

Endocrine Pathology, Vol. 12, Iss. 3, 2001-09 ,pp. : 307-313

Humana Press, Inc

Access to resources Recommend Favorite